This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-4277v1 69/13/5553    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bandi, N. Articles by Vassella, E. Search for Related Content PubMed PubMed Citation Articles by Bandi, N. Articles by Vassella, E.

miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non–Small Cell Lung Cancer

Institute of Pathology, University of Bern, Bern, Switzerland

Requests for reprints: Erik Vassella, Institute of Pathology, University of Bern, Murtenstrasse 31, CH-3010 Bern, Switzerland. Phone: 41-31-632-9943; Fax: 41-31-381-8764; E-mail: erik.vassella{at}pathology.unibe.ch.

Key Words: microRNA • non-small cell lung cancer • cell cycle control • cyclin • retinoblastoma

MicroRNAs (miRNA) are negative regulators of gene expression at the posttranscriptional level, which are involved in tumorigenesis. Two miRNAs, miR-15a and miR-16, which are located at chromosome 13q14, have been implicated in cell cycle control and apoptosis, but little information is available about their role in solid tumors. To address this question, we established a protocol to quantify miRNAs from laser capture microdissected tissues. Here, we show that miR-15a/miR-16 are frequently deleted or down-regulated in squamous cell carcinomas and adenocarcinomas of the lung. In these tumors, expression of miR-15a/miR-16 inversely correlates with the expression of cyclin D1. In non–small cell lung cancer (NSCLC) cell lines, cyclins D1, D2, and E1 are directly regulated by physiologic concentrations of miR-15a/miR-16. Consistent with these results, overexpression of these miRNAs induces cell cycle arrest in G₁-G₀. Interestingly, H2009 cells lacking Rb are resistant to miR-15a/miR-16–induced cell cycle arrest, whereas reintroduction of functional Rb resensitizes these cells to miRNA activity. In contrast, down-regulation of Rb in A549 cells by RNA interference confers resistance to these miRNAs. Thus, cell cycle arrest induced by these miRNAs depends on the expression of Rb, confirming that G₁ cyclins are major targets of miR-15a/miR-16 in NSCLC. Our results indicate that miR-15a/miR-16 are implicated in cell cycle control and likely contribute to the tumorigenesis of NSCLC. [Cancer Res 2009;69(13):5553–9]

This article has been cited by other articles:

				L. Santarpia, M. Nicoloso, and G. A Calin MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype Endocr. Relat. Cancer, March 1, 2010; 17(1): F51 - F75. [Abstract] [Full Text] [PDF]